Varicella Vaccine, Live (with WFI in ampoule)

Product Description

Good safety of gelatin-free
The first lyophilized Varicella Vaccine, containing no gelatin from animals, invented and produced in China. Getting rid of gelatin from varicella vaccine can significantly decrease the ratio of anaphylaxis incidence. 
 
Long validity period by good stability
The first approved varicella vaccine with *6 months of validity period in the world.
Adopting BH*2 stabilizer with own IP rights (Chinese patent granted No.: ZL***********1.6, International patent application No.: PCT/CN***9/*****5) greatly enhances the stability of the product and ensures the validity period for *6 months under the storage condition.
 
Better protection with high titer and immune efficacy
Its documented that compared with the varicella vaccine of low titer, high titer vaccine can reduce breakthrough cases by nearly *5% after vaccination.
Of all released batches of Varicella Vaccine from BCHT, the titers are not less than ****0 PFU/dose(4.0lgPFU/dose) tested by National Institutes for Food and Drug Control.
 
Two-dose immunization & Perfect protection
BCHT Varicella Vaccine, Live could be used for basic immunization, booster immunization and two-dose immunization strategies for healthy varicella susceptible people over *2 months old.
 
Multiply dosage forms & More convenient
ampoule, vial and prefilled syringe. Adopting BD prefilled syringe, more convenient and comfortable.